The Claim
In observational studies evaluating melatonin safety, comparing prescription-based cohorts with populations that may include over-the-counter users introduces significant misclassification bias, which artificially inflates risk estimates for the exposed group.
What the research says
Challenges is higher
Challenge is ahead, but a single strong supporting study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When researchers study the safety of melatonin, mixing people who get it from a doctor with those who buy it over the counter can mess up the data. This mistake makes it look like the prescription version is more dangerous than it really is.
See the scientific wording
Observational studies assessing melatonin safety are prone to significant misclassification bias when prescription-based cohorts are compared against populations that may include over-the-counter users, artificially inflating risk estimates in the exposed group.
What the research says
1 studyThe study found higher heart failure and death rates in people taking prescription melatonin, but it did not check whether mixing prescription and over-the-counter users skewed the results, so it does not support the claim that the high risks are just a data collection error.
Related videos
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.